Agricoltura
Jennewein Biotechnologie Develops New Fermentation Technology for Human Milk Oligosaccharides and Expands its Product Portfolio
Jennewein Biotechnologie is a leading international industrial biotechnology company with a range of products in the field of complex oligosaccharides (HMOs) and rare monosaccharides. The company manufactures an extensive portfolio of innovative HMO products, such as 2'-fucosyllactose, 3'-fucosyllactose and lacto- -tetraose. These rare sugars are used in the food industry (particularly infant milk formulas), the pharmaceutical industry, and the cosmetic industry. The manufacturing process involves state-of-the-art fermentation techniques. In 2015, the US Food and Drug Administration (FDA) granted Jennewein Biotechnologie a license to market 2'-fucosyllactose in the USA . This was followed in 2017 by European Union marketing authorisation under the Novel Food Regulation.
Press contact:
Dr. Bettina Gutierrez
+49(0)2224-98810-797
bettina.gutierrez@jennewein-biotech.de